TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes With Increased Blasts

Clinical trial NCT03816319 · RECRUITING

Trial details

NCT number: NCT03816319
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Myelodysplastic Syndrome With Excess Blasts Recurrent Acute Myeloid Leukemia Recurrent Myelodysplastic Syndrome Recurrent Myelodysplastic Syndrome/Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Myelodysplastic Syndrome Refractory Myelodysplastic Syndrome/Acute Myeloid Leukemia

Start date: 2025-03-12
Primary completion: 2026-10-24
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.